MAPT and Alzheimer disease: Recently, it was shown that DOPEGAL activates asparagine endopeptidase, resulting in the production of hyperphosphorylated tau protein and Aβ (Kang et al., 2020) and leading to AD (Kang et al., 2020, 2022).